NO20040258L - Preparat for behandling av negleinfeksjoner med nitrogenoksid - Google Patents

Preparat for behandling av negleinfeksjoner med nitrogenoksid

Info

Publication number
NO20040258L
NO20040258L NO20040258A NO20040258A NO20040258L NO 20040258 L NO20040258 L NO 20040258L NO 20040258 A NO20040258 A NO 20040258A NO 20040258 A NO20040258 A NO 20040258A NO 20040258 L NO20040258 L NO 20040258L
Authority
NO
Norway
Prior art keywords
treatment
preparation
nitric oxide
nail infections
nail
Prior art date
Application number
NO20040258A
Other languages
English (en)
Norwegian (no)
Inventor
Nigel Benjamin
Original Assignee
Univ Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Aberdeen filed Critical Univ Aberdeen
Publication of NO20040258L publication Critical patent/NO20040258L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
NO20040258A 2001-08-03 2004-01-20 Preparat for behandling av negleinfeksjoner med nitrogenoksid NO20040258L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0119011.5A GB0119011D0 (en) 2001-08-03 2001-08-03 Treatment of nail infections
PCT/GB2002/003575 WO2003013489A1 (en) 2001-08-03 2002-08-02 Treatment of nail infections with no

Publications (1)

Publication Number Publication Date
NO20040258L true NO20040258L (no) 2004-03-29

Family

ID=9919789

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040258A NO20040258L (no) 2001-08-03 2004-01-20 Preparat for behandling av negleinfeksjoner med nitrogenoksid

Country Status (23)

Country Link
US (2) US20050037093A1 (ko)
EP (1) EP1411908B1 (ko)
JP (1) JP2005501069A (ko)
KR (1) KR20040031780A (ko)
CN (1) CN1321633C (ko)
AT (1) ATE296094T1 (ko)
AU (1) AU2002318001B2 (ko)
BR (1) BR0211390A (ko)
CA (1) CA2453243C (ko)
DE (1) DE60204322T2 (ko)
ES (1) ES2242042T3 (ko)
GB (1) GB0119011D0 (ko)
HR (1) HRP20040059B1 (ko)
HU (1) HUP0401190A3 (ko)
IL (2) IL159724A0 (ko)
MX (1) MXPA04000670A (ko)
NO (1) NO20040258L (ko)
NZ (1) NZ530577A (ko)
PL (1) PL213555B1 (ko)
PT (1) PT1411908E (ko)
RU (1) RU2298403C2 (ko)
WO (1) WO2003013489A1 (ko)
ZA (1) ZA200400491B (ko)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
CA2536827C (en) * 2003-07-09 2014-09-16 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
WO2006100154A1 (en) * 2005-03-24 2006-09-28 Nolabs Ab Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor
US8557300B2 (en) * 2005-05-19 2013-10-15 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
ES2731298T3 (es) 2005-05-27 2019-11-14 Univ North Carolina Chapel Hill Partículas de liberación de óxido nítrico para agentes terapéuticos de óxido nítrico y aplicaciones biomédicas
JP5165217B2 (ja) * 2006-07-07 2013-03-21 生化学工業株式会社 ゲル状又はフィルム状組成物並びにその製造方法及び用途
GB0618711D0 (en) * 2006-09-22 2006-11-01 Univ Exeter Agricultural treatment
US20090130233A1 (en) * 2007-10-24 2009-05-21 Baker Christopher G Two part lotion
AU2008322437B2 (en) 2007-11-15 2013-11-07 Louisiana State University Use of nitrite salts in chronic ischemia
AU2008345034A1 (en) * 2007-12-27 2009-07-09 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide - donating compounds and uses thereof
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs
EP2334279A4 (en) * 2008-10-16 2013-03-20 Novan Inc STAIN OXIDE RELEASING PARTICLES FOR MOUTH CARE APPLICATIONS
US20120003293A1 (en) * 2008-10-30 2012-01-05 Chris Miller Nitric oxide-releasing dressings
US9241999B2 (en) 2009-06-15 2016-01-26 Board Of Regents Of The University Of Texas System Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system
ES2958410T3 (es) 2009-08-21 2024-02-08 Novan Inc Geles tópicos
CN102695528B (zh) 2009-08-21 2016-07-13 诺万公司 创伤敷料、其使用方法及其形成方法
US20110086234A1 (en) * 2009-10-13 2011-04-14 Nathan Stasko Nitric oxide-releasing coatings
JP5758904B2 (ja) 2009-10-14 2015-08-05 セラバスク インコーポレーテッド ニトライトの医薬製剤及びそれらの使用
WO2011155887A1 (en) * 2010-06-07 2011-12-15 Topical Pharma Ab Kit for the treatment of onychomycosis by nitric oxide
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
EP2681286B1 (en) 2011-02-28 2018-08-15 Novan, Inc. Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
EP2691087A2 (en) 2011-03-31 2014-02-05 László Gábor Szabó Pharmaceutical composition containing no, process for the preparation and use thereof
ES2804263T3 (es) 2011-07-05 2021-02-05 Novan Inc Composiciones tópicas
US9737362B2 (en) * 2011-07-06 2017-08-22 Boston Scientific Scimed, Inc. Tissue cutting systems and methods
EP2833721B1 (en) 2012-03-14 2021-02-17 Novan Inc. Nitric oxide releasing pharmaceutical compositions
ES2741146T3 (es) 2013-02-20 2020-02-10 The Board Of Supervisors Of The Louisiana State Univ Mechanical And Agricultural College Formulaciones farmacéuticas de nitrio y sus usos
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US9095518B2 (en) 2013-08-01 2015-08-04 Liqwd, Inc. Methods for fixing hair and skin
ES2836132T3 (es) 2013-08-08 2021-06-24 Novan Inc Composiciones tópicas y métodos de uso de las mismas
AU2015229626B2 (en) 2014-03-14 2021-05-20 Sanotize Research And Development Corp. Treating diseases using nitric oxide releasing solutions
PT3142637T (pt) 2014-05-16 2020-10-15 Olaplex Inc Formulações e métodos de tratamento de queratina
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
AU2015287674B2 (en) 2014-07-11 2019-11-21 Novan, Inc. Topical antiviral compositions and methods of using the same
WO2016010988A1 (en) 2014-07-14 2016-01-21 Novan, Inc. Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
CA2919733A1 (en) 2014-08-08 2016-02-08 Novan, Inc. Topical compositions and methods of using the same
KR102661331B1 (ko) 2015-04-24 2024-04-30 올라플렉스, 인코포레이티드 릴렉싱된 헤어의 처리 방법
WO2017019614A1 (en) 2015-07-28 2017-02-02 Novan, Inc. Combinations and methods for the treatment and/or prevention of fungal infections
WO2017151905A1 (en) 2016-03-02 2017-09-08 Novan, Inc. Compositions for treating inflammation and methods of treating the same
JP6899845B2 (ja) 2016-04-13 2021-07-07 ノヴァン，インコーポレイテッド 感染症を治療するための組成物、システム、キットおよび方法
US9872821B1 (en) 2016-07-12 2018-01-23 Liqwd, Inc. Methods and formulations for curling hair
US11534382B2 (en) 2017-06-19 2022-12-27 Novan, Inc. Topical compositions and methods of using the same
CN112165935A (zh) 2018-03-01 2021-01-01 诺万公司 一氧化氮释放性栓剂及其使用方法
US11472705B2 (en) 2018-03-13 2022-10-18 Sanotize Research And Development Corp. Nitric oxide releasing compositions
RU2704782C1 (ru) * 2018-10-09 2019-10-30 Елена Владимировна Герасимчук Способ криогенного лечения онихомикоза
CA3142101A1 (en) 2019-06-04 2020-12-10 Thirty Holdings Limited Methods and compositions for generating nitric oxide and uses thereof
CN114126629A (zh) 2019-06-04 2022-03-01 三十呼吸有限公司 用于生成一氧化氮的方法和组合物及其用于经由呼吸道输送一氧化氮的用途
BR112022021454A2 (pt) 2020-04-23 2023-01-31 Thirty Respiratory Ltd Óxido nítrico ou composições liberadoras de óxido nítrico para uso no tratamento de sars-cov e sars-cov-2
EP4138794A1 (en) 2020-04-23 2023-03-01 Thirty Respiratory Limited Methods and compositions for treating and combatting tuberculosis
JP2023533588A (ja) * 2020-07-16 2023-08-03 サノタイズ リサーチ アンド ディベロップメント コープ． 一酸化窒素療法に反応する状態を治療する方法
RU2769437C1 (ru) * 2021-07-08 2022-03-31 Светлана Николаевна Абрамова Способ восстановления роста ногтя

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY128187A (en) * 1993-06-23 2007-01-31 Icn Switzerland Ag Preparation for skin and mucous membrane
GB9804469D0 (en) * 1998-03-02 1998-04-29 Univ Aberdeen Antiviral composition
DE69532921T2 (de) 1994-02-21 2005-04-14 Aberdeen University, Aberdeen Angesäuertes nitrit zur verwendung als antimikrobielles mittel
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide

Also Published As

Publication number Publication date
IL159724A (en) 2006-04-10
JP2005501069A (ja) 2005-01-13
PT1411908E (pt) 2005-08-31
ATE296094T1 (de) 2005-06-15
WO2003013489A1 (en) 2003-02-20
RU2298403C2 (ru) 2007-05-10
US20100015253A1 (en) 2010-01-21
HUP0401190A3 (en) 2008-08-28
PL366579A1 (en) 2005-02-07
RU2004101765A (ru) 2005-03-10
CN1564681A (zh) 2005-01-12
HRP20040059A2 (en) 2004-08-31
CN1321633C (zh) 2007-06-20
EP1411908A1 (en) 2004-04-28
ES2242042T3 (es) 2005-11-01
ZA200400491B (en) 2005-04-22
CA2453243A1 (en) 2003-02-20
US9381381B2 (en) 2016-07-05
CA2453243C (en) 2012-01-03
HRP20040059B1 (en) 2008-05-31
IL159724A0 (en) 2004-06-20
BR0211390A (pt) 2004-08-17
GB0119011D0 (en) 2001-09-26
DE60204322D1 (de) 2005-06-30
HUP0401190A2 (hu) 2004-11-29
MXPA04000670A (es) 2004-10-27
US20050037093A1 (en) 2005-02-17
DE60204322T2 (de) 2006-01-26
AU2002318001B2 (en) 2007-02-15
PL213555B1 (pl) 2013-03-29
NZ530577A (en) 2007-01-26
EP1411908B1 (en) 2005-05-25
KR20040031780A (ko) 2004-04-13

Similar Documents

Publication Publication Date Title
NO20040258L (no) Preparat for behandling av negleinfeksjoner med nitrogenoksid
MXPA05011522A (es) Derivados de 2-acilamino-4-feniltiazol, metodo para su preparacion y su aplicacion en terapeutica.
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
BR112012021337A2 (pt) formulações de apixaban.
NO20074823L (no) Rasagilin-formuleringer med forbedret innholdsensartethet
WO2004062613A3 (en) Hiv integrase inhibitors
HK1085140A1 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
ATE451376T1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
MA32544B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
ATE245152T1 (de) Dioxocyclopentylhydroxamsäure
ATE484508T1 (de) Furylverbindungen
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
MY131964A (en) 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
CY1115961T1 (el) Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate)
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
DE60316821D1 (de) Aminobenzothiazolverbindungen mit nos-hemmender wirkung
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
ATE420089T1 (de) Substituierte azachinazoline mit antiviraler wirkung
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
DE60213802D1 (de) Cak inhibitoren und deren verwendungen
WO2005034857A8 (en) Methods and compositions comprising diamines as new anti-tubercular therapeutics
ATE363890T1 (de) Kationische polymerisate und deren verwendung in kosmetischen formulierungen
BR0111785A (pt) Composições e métodos para tratamento de candidìase
DE60325838D1 (de) Imidazoquinolinamine als adjuvantien für hiv dna vakzine
DK1537132T3 (da) Salt af mortin-6-glucuronid

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application